Plus Therapeutics Inc
News Catalyst · detected 2026-07-16 14:10 · Healthcare · Biotechnology
Risk : Reward
1 : 10.0
Likelihood
31%
Historical win rate of this setup typeRisk multiplier
1.00×
Normal sizingScore
55
Time to reward
1 week
Estimated holding period for reward realizationExpected R
-0.01R
From 232 closed setups · bucket: news:49|mag:unknownTrade levels
Entry4.03
Stop3.69
Risk / share0.34
Target 1 (3R)5.05
Target 2 (5R)5.73
Target 3 (10R)7.43
Rationale
News id
12424
Category
PartnershipAnnounced
Headline
Plus Therapeutics and Genomic Testing Cooperative Partner to Integrate Next-Generation Sequencing Into the CNSide CSF Assay Platform
Published utc
2026-07-16T07:30:00
Risk multiplier
1
Stop template
PrevDayLow
Sector
Healthcare
Industry
Biotechnology
Market cap
27.74M
Magnitude usd
—
Magnitude anchor
—
Magnitude percent of mcap
—
Magnitude bonus
0
Gann confluence
In zone
In zone
Current zone score 8 · reaction rate 99% · 260 clusters tracked · bars used 1254
| Date | Price | Score | Price levels | Time levels |
|---|---|---|---|---|
| 2022-01-05 | 3.88 | 15.75 | 11 | 42 |
| 2022-01-05 | 4.82 | 10.15 | 9 | 42 |
| 2022-01-05 | 3.18 | 7.75 | 5 | 42 |
| 2022-01-05 | 4.32 | 6.71 | 6 | 42 |
| 2022-01-05 | 5.39 | 6.62 | 7 | 42 |
| 2022-01-05 | 2.71 | 5.79 | 5 | 42 |
| 2022-01-05 | 5.89 | 5.23 | 5 | 42 |
| 2022-01-05 | 2.22 | 4.46 | 3 | 42 |
| 2022-01-05 | 1.39 | 3.57 | 3 | 42 |
| 2022-02-23 | 3.88 | 2.46 | 11 | 6 |